source
- Claret says it latest fund will have larger focus on European life sciencesEuropean firm Claret Capital Partners has raised €575 million in its latest round, dubbed Fund IV, and a sizable portion will be lent out to local biotech companies and manufacturers. Roughly one t…Endpoints · 20m ago↗ source
- ADA panel still reviewing expulsions from June conference, further actions possibleThe American Diabetes Association released top‑line findings on Sept. 1 from an internal panel tasked with reviewing the June 5 expulsion of five members at its New Orleans conference. The full re…
- Novartis pauses CAR-T trials after three patient deaths